Document is current
Any future updates will be listed below
-
Authors
Olsen, T. Anders
Martini, Dylan J.
Evans, Sean T.
Goldman, Jamie M.
Bilen, Mehmet Asim https://orcid.org/0000-0002-1955-5626
-
Funding
Funding for this research was provided by:
National Institutes of Health (P30CA138292)
Breen Family Foundation
- License Information
-
More Information
Article History
Received: 18 September 2020
Accepted: 15 December 2020
First Online: 19 February 2021
Ethics approval and consent to participate
: This study was conducted in accordance with the fundamental principles of the Declaration of Helsinki.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent form is available for review by the Editor-in-Chief of this journal.
: Mehmet A. Bilen has acted as a paid consultant for and/or as a member of the advisory boards of Exelixis, Bayer, BMS, Eisai, Pfizer, AstraZeneca, Janssen, Genomic Health, Nektar, and Sanofi and has received grants to his institution from Xencor, Bayer, Bristol-Myers Squibb, Genentech/Roche, Seattle Genetics, Incyte, Nektar, AstraZeneca, Tricon Pharmaceuticals, Peleton Therapeutics, and Pfizer for work performed as outside of the current study.
